In the present study, we report two net neutral rhenium tricarbonyl complexes; fac-[Re(CO)3(L1)] (C1) and fac-[Re(CO)3(L2)] (C2) synthesized by treating fac-[Re(CO)3(H2O)3]+ with two novel diethylenetriamine (dien) derivatized tridentate ligands; N(SO2chlorobenz)dienH (L1-H) and N(SO2iodobenz)dienH (L2-H) attached to a sulfonamide group. The compounds were characterized by UV–Visible, fluorescence, FTIR and 1H NMR spectroscopic methods together with single crystal X-ray diffraction analysis. High fluorescence intensities were observed for the ligands in the visible range while quenched fluorescence intensities were observed for their corresponding Re complexes. X-ray structural data revealed that diethylenetriamine is coordinated in a tridentate mode with the Re metal. 1H NMR spectra confirm that, the sulfonamide nitrogen deprotonates, prior to complexation with the metal, and that the two protons of the other terminal nitrogen orient toward (endo-NH) and away (exo-NH) from the CO ligands. Both ligands comply with the Lipinski’s rule of 5 and exhibit an excellent bioavailability score of 0.55. Moreover, both ligands are predicted to bind with sigma-1 receptors with calculated Moldock scores of -94.83, -91.93, -121.21 and -119.95 for L1-H, L2-H, C1 and C2, respectively. These results align well with the findings from the in vitro antiproliferative assay. In BSA binding study, the calculated binding constant, Kb values for L1-H, L2-H, C1 and C2 are 7.44 × 104 M−1, 22.79 × 104 M−1, 54.27 × 104 M−1 and 2.62 × 104 M−1, respectively, indicating their potential serum albumin binding properties. The promising outcomes of in silico analysis, in vitro antiproliferative assay and BSA binding study of these sulfonamide ligands and Re complexes reveal that these compounds may be good candidates to be developed as anticancer drug leads.
扫码关注我们
求助内容:
应助结果提醒方式:
